![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Regeneron Scales Up Manufacturing of COVID-19 Antibody Cocktail
Regeneron Scales Up Manufacturing of COVID-19 Antibody Cocktail
Regeneron said it will produce hundreds of thousands of doses of its potential COVID-19 antibody treatment REGN-COV2 by the end of August.
The company expects to begin clinical studies of the antibody “cocktail” therapy next month.
Regeneron is also conducting a phase 2/3 trial with Sanofi to evaluate its rheumatoid arthritis treatment Kevzara (sarilumab) for treating severe COVID-19 infections.
Upcoming Events
-
18Jul
-
21Oct